Drug Shortage Report for NAT-RIZATRIPTAN ODT

Last updated on 2019-02-07 History
Report ID 67512
Drug Identification Number 02436604
Brand name NAT-RIZATRIPTAN ODT
Common or Proper name Rizatriptan Benzoate
Company Name NATCO PHARMA (CANADA) INC
Active Ingredient(s) RIZATRIPTAN
Strength(s) 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size 6
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-01-01
Actual start date
Estimated end date 2019-02-06
Actual end date 2019-02-06
Shortage status Resolved
Updated date 2019-02-07
Company comments Available product is short-dated.
Health Canada comments
Contact Address 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200
MISSISSAUGA, ONTARIO
CANADA L5N 1P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2019-02-07 French Compare
v8 2019-02-05 French Compare
v7 2019-02-05 English Compare
v6 2019-02-04 French Compare
v5 2019-02-04 English Compare
v4 2019-01-23 English Compare
v3 2019-01-11 English Compare
v2 2018-11-23 French Compare
v1 2018-11-23 English Compare